JOINT DEVELOPMENT AGREEMENTJoint Development Agreement • November 3rd, 2011 • Genomatica Inc • Industrial organic chemicals • Delaware
This Joint Development Agreement (this “JDA”), is dated as of this 15th day of March, 2011 (“Effective Date”), by and between Genomatica, Inc., a Delaware corporation with principal offices located at 10520 Wateridge Circle, San Diego, California 92121 (hereinafter referred to as “Genomatica”), and Tate & Lyle Ingredients Americas, Inc., a Delaware corporation with principal offices located at 2200 East Eldorado Street, Decatur, Illinois 62521 (hereinafter referred to as “T&L”).
JOINT DEVELOPMENT AGREEMENTJoint Development Agreement • November 3rd, 2011 • Genomatica Inc • Industrial organic chemicals • Delaware
This Joint Development Agreement (this “JDA”), is dated as of this 15th day of April, 2011 (“Effective Date”), by and between Genomatica, Inc., a Delaware corporation with principal offices located at 10520 Wateridge Circle, San Diego, California 92121 (hereinafter referred to as “Genomatica”), and Chemtex Italia S.r.l., an Italian corporation with principal offices located at Strada Ribrocca n. 11, 15057 Tortona (AL), Italy (hereinafter referred to as “Chemtex”).
LICENSE AGREEMENTLicense Agreement • November 3rd, 2011 • Genomatica Inc • Industrial organic chemicals
This License Agreement, effective upon the date of last signature herein (the “Effective Date”), by and between The Penn State Research Foundation (hereinafter referred to as “PSRF”), a non-profit corporation duly organized and existing under the laws of the Commonwealth of Pennsylvania and having an office at 304 Old Main, University Park, PA 16802, and Genomatica, Inc., a corporation organized under the laws of the State of California (hereinafter referred to as “LICENSEE”), having its principal office at 5405 Morehouse Drive, Suite 210, San Diego, CA 92121.
Re: Chief Technology Officer Agreement with Genomatica, Inc.Genomatica Inc • November 3rd, 2011 • Industrial organic chemicals • California
By this letter, you and Genomatica, Inc. (the “Company”) agree to amend and restate the terms of your position as Executive Vice President and Chief Technology Officer pursuant to the terms of this letter agreement (this “Agreement”). This Agreement is made and entered into as of the last day either party executes this Agreement (the “Effective Date”) and shall supersede any prior written or oral agreements relating to the conditions of your employment with the Company. You and the Company hereby agree as follows:
JOINT DEVELOPMENT AGREEMENT Between Genomatica, Inc. and WM Organic Growth, Inc.Agreement • November 3rd, 2011 • Genomatica Inc • Industrial organic chemicals • New York
THIS AGREEMENT is entered into by and between Genomatica, Inc. (“Genomatica”), a Delaware corporation, and WM Organic Growth, Inc. (“WMOG”), a Delaware corporation, to be effective as of the 1st day of December, 2010 (the “Effective Date”).
SUPPLY RIGHTS AGREEMENTSupply Rights Agreement • November 3rd, 2011 • Genomatica Inc • Industrial organic chemicals
THIS SUPPLY RIGHTS AGREEMENT (this “Agreement”) is made as of the 1st day of December, 2010 by and between Genomatica, Inc., a Delaware corporation (“Genomatica”), and Waste Management National Services, Inc., a Delaware corporation (“WM”). Genomatica and WM are occasionally referred to herein individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENT BETWEEN GENOMATICA, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. […***…] CASE NO. […***…] CASE NO. […***…] CASE NO. […***…] CASE NO. […***…] CASE NO. […***…] CASE NO. […***…]License Agreement • November 3rd, 2011 • Genomatica Inc • Industrial organic chemicals • California
Re: Executive Vice President and Chief Financial Officer Agreement with Genomatica, Inc. Dear Mike,Genomatica Inc • November 3rd, 2011 • Industrial organic chemicals • California
Genomatica, Inc. (the “Company”) is pleased to offer you the position of Executive Vice President and Chief Financial Officer pursuant to the terms of this letter agreement (this “Agreement”). This Agreement is made and entered into as of the last day either party executes this Agreement. Should you accept this offer, your start date shall be no later than August 22, 2011 (the “Effective Date”). This offer will expire on July 11, 2011. You and the Company hereby agree as follows:
